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ABSTRACT 
There is modest clinical evidence supporting the safe use of Chondroitin Sulfate (CS) for pain 
management in arthritis patients.(Singh et al., 2015) In the United States CS is used as a dietary 
ingredient in dietary supplements intended to support joint health, while in the European Union 
countries CS is included in treatment regimens for osteoarthritis pain management. Accordingly 
the United States Pharmacopeia has set CS quality standard for dietary supplement grade CS, 
while the European Pharmacopoeia’s quality standard are for pharmaceutical grade chondroitin 
sulfate. It has been reported that specific activity of CS depends on the quality: such as 
chondroitin sulfate structure and properties that determine its bioavailability and efficacy.(Volpi, 
2009)  Thus CS quality affects therapeutic utility of commercial preparations, particularly 
products manufactured to meet pharmaceutical standards versus products manufactured to meet 
food grade standards (dietary supplements). In this poster we discuss various testing methods 
available that can be used to establish identity, purity, strength, composition and limit of 
contaminants of CS. To ensure high quality and purity of CS material, we recommend the use of 
compendial CS standards with complementary analytical procedures as well as adherence to 
proper quality systems, good laboratory practices and training. These practices will ensure that 
only high quality CS is used in medicines and dietary supplements so that patients and 
consumers can benefit appropriately. 
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